StonvexLoading…
StonvexStonvexStonvexCore line items from GCTS's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
Quarterly filings sourced directly from SEC EDGAR. Real-time earnings actuals are in the Earnings panel above.
| Metric | Q3 2026 (Est.) Expected 2026-08-10 | Q1 2026 2026-03-31 | Annual 2025 2025-12-31 | Q3 2025 2025-09-30 | Q2 2025 2025-06-30 |
|---|---|---|---|---|---|
Revenue | $3.37M | $1.92M | $2.87M | $2.11M | $1.68M |
Operating Income | Not available | $-6.13M | $-36.54M | $-24.59M | $-15.33M |
Net Income | Not available | $-9.86M | $-43.37M | $-34.35M | $-13.54M |
EPS (Diluted) | $-0.08 | $-0.15 | $-0.82 | $-0.67 | $-0.41 |
Total Assets | Not available | $22.38M | $15.64M | $24.27M | $17.62M |
Total Liabilities | Not available | $96.31M | $98.94M | $104.42M | $87.59M |
Cash & Equivalents | Not available | $7.18M | $590.00K | $8.34M | $1.27M |
Free Cash Flow OCF − CapEx | Not available | $-7.49M | $-33.09M | $-24.59M | $-16.80M |
Shares Outstanding | Not available | 72.59M | 58.14M | 56.47M | 55.78M |